Global Ganja Report

Many rural California communities have high expectations over the prospect of commercial cannabis cultivation, officially licensed by local authorities under provisions of the Medical Cannabis Regulation and Safety Act (MMRCA), which was passed by Sacramento last year. Humbold County issued its first commercial cultivation licenses this summer. Now a less likely entry, Kern County in the conservative southern end of the Central Valley, has seen its first licenses. These were issued by the municipality of California City, where officials expressed some surprise at their own actions. "It's a new industry for us. It kind of came and dropped in our laps," city manager Tom Weil told Bakersfield's KBAK. "It's not something we were looking for."

The British government's Medicines & Healthcare Regulatory Agency (MHRA) on Oct. 11 issued a finding that cannabidiol (CBD) has a "restoring, correcting or modifying" effect on "physiological functions." The Independent calls the move "a potential milestone in the campaign to legalise cannabis and bring about evidence-based laws regarding drugs."  The review of CBD, a non-psychoactive cannabinoid increasingly studied for its therapeutic value, was undertaken following discussions with MediPen, a London-based company that seeks to market a CBD vaporizer.

German authorities just took the unprecedented move to allow a medical marijuana patient to cultivate at home. The obscurely named Federal Institute for Drugs and Medical Devices (BfArM) announced on Oct. 2 that a multiple sclerosis sufferer from Mannheim, in Baden-Württemberg state, will be permitted to grow a maximum of 130 plants a year. But the grow must be confined to an extremely restricted space in his bathroom. Terms of the permit stipulate that any leftover plants or harvested herb must be destroyed, and the buds must be kept in a "secure storage unit."

Oakland's KTVU  on Oct. 5 noted a miltestone for the East Bay city: exactly 10 years of operation for Harborside Health Center, the foremost "pioneering enterprise" in California's cannabis industry. "The world's attitude towards cannabis has shifted massively in the course of the 10 years that Harborside has been open," box-store dispensary founder Steve DeAngelo told the station, noting legalization of recreational use in four states and the District of Columbia. "So we have seen really a massive, tectonic shift in attitudes towards cannabis." KTVU hails Harborside as "a solid, respected business with 200 employees and contractors, serving 200,000 patients."

With California preparing to vote on a marijuana legalization initiative in November,  the city of Oakland is seeking not only tax revenues but a direct cut of profits from local cannabis business. A measure introduced in the City Council would require any new Oakland cannabis company to make the city government a 25% partner. Companies that don't cut Oakland in would not get a permit and therefore not be allowed to operate under local law—or state law, which mandates compliance with municipal ordinances.

Last month, when the DEA dashed activist hopes for a rescheduling of cannabis, it also issued another lesser-noted decision—to put the psychoactive herb kratom in the same Schedule I classification as pot, that for the most dangerous drugs with no medical use. Advocates have launched a White House petition against the kratom ban, and have already won the required 100,000 signatures to trigger an administration reponse. The DEA decision takes effect on Sept. 30, while the White House has 60 days to respond to the petition, under its own policy.

After much speculation that the US Drug Enforcement Agency (DEA) would reschedule cannabis this summer, the agency on Aug. 11 dashed petitioners' hopes, rejecting their request to remove its classification as a Schedule I dangerous drug. The DEA denied two separate requests by former state governors to re-classify cannabis as a Schedule II drug or lower. The agency stated (PDF) that the Department of Health and Human Services (HHS) has "concluded that marijuana has high potential for abuse, has no accepted medical use in the United States, and lacks an acceptable level of safety for use even under medical supervision." Tthe DEA did propose a new policy that would allow universities to apply to grow cannabis for research. Until now, the University of Mississippi had a monopoly on cultivation for study. (Jurist)

A police raid of a Southern California medical marijuana dispensary was caught on hidden cameras—leading to accusations that officers exceeded their legal authority during the operation. "These guys were doing this to shut down a business without due process because they don't like it," Matthew Pappas, attorney for the now-closed Costa Mesa Collective told the Orange County Register in an Aug. 4 report. "They became judge, jury and executioner."